Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies

被引：0
|
作者：
Unger, Joseph M. [1 ]
Hershman, Dawn L. [2 ]
Osarogiagbon, Raymond U. [3 ]
Gothwal, Anirudh [4 ]
Anand, Seerat [5 ]
Dasari, Arvind [5 ]
Overnman, Michael [5 ]
Loree, Jonathan M. [6 ]
Raghav, Kanwal [5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Columbia Univ, New York, NY USA
[3] Baptist Canc Ctr, Memphis, TN USA
[4] Baylor Univ, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] BC Canc, Vancouver, BC, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4344
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program
    Minasian, Lori M.
    Tangen, Catherine M.
    Wickerham, Lawrence
    SEMINARS IN ONCOLOGY, 2015, 42 (05) : 748 - 763
  • [22] Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials
    Filipa Lynce
    Matthew J. Blackburn
    Ling Cai
    Heping Wang
    Larry Rubinstein
    Pamela Harris
    Claudine Isaacs
    Paula R. Pohlmann
    Breast Cancer Research and Treatment, 2018, 168 : 35 - 41
  • [23] Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the national cancer institute-sponsored clinical trials networks
    Bruner, Deborah Watkins
    Bryan, Charlene J.
    Aaronson, Neil
    Blackmore, C. Craig
    Brundage, Michael
    Cella, David
    Ganz, Patricia A.
    Gotay, Carolyn
    Hinds, Pamela S.
    Kornblith, Alice B.
    Movsas, Benjamin
    Sloan, Jeff
    Wenzel, Lari
    Whalen, Giles
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5051 - 5057
  • [24] Discussions of Cancer Clinical Trials with the National Cancer Institute's Cancer Information Service
    Byrne, Margaret M.
    Kornfeld, Julie
    Vanderpool, Robin
    Belanger, Marc
    JOURNAL OF HEALTH COMMUNICATION, 2012, 17 (03) : 319 - 337
  • [25] CURRENT SITUATIONS AND ISSUES FOR PHASE I CLINICAL TRIALS SPONSORED BY PHARMACEUTICAL COMPANIES CONDUCTED AT REGIONAL CANCER CENTER HOSPITALS IN JAPAN
    Aogi, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 71 - 71
  • [26] Benchmarks of success in radiotherapy vs systemic therapy: National Clinical Trials Network (NCTN) randomized controlled trials sponsored by the National Cancer Institute (NCI)
    Sanford, Nina N.
    Shi, Qian
    Hein, David M.
    Hall, William A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
  • [27] Geriatric enrollment patterns in clinical trials at a National Cancer Institute
    Khazak, Andre
    Parsa, Kian
    Elias, Evelyn
    Liaw, Bobby Chi-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] National Cancer Institute-Supported Clinical Trials Networks
    Abrams, Jeffrey
    Kramer, Barry
    Doroshow, James H.
    Varmus, Harold
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 293 - 293
  • [29] National Cancer Institute: Restructuring to Support the Clinical Trials of the Future
    Good, Marjorie
    Castro, Kathleen
    Denicoff, Andrea
    Finnigan, Shanda
    Parreco, Linda
    St Germain, Diane
    SEMINARS IN ONCOLOGY NURSING, 2020, 36 (02)
  • [30] The National Cancer Institute's Clinical Trials Innovation Unit
    Morris, Michael J.
    Prindiville, Sheila
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (12) : 663 - 665
12345